Mainsail Partners Invests in Bio-Optronics

We represented Mainsail Partners in its $30 million growth equity investment in Bio-Optronics. Bio-Optronics will use the capital and Mainsail’s support to accelerate product development, enhance customer service, and grow sales and marketing.

Bio-Optronics is a leading software and services company that creates user-focused applications for healthcare organizations that positively impact business performance.

Mainsail Partners is a San Francisco-based growth equity firm that invests in bootstrapped software companies.

You Also May Be Interested In:

  • Co-counsel to Methodist Le Bonheur Healthcare (MLH) in its efforts to obtain a Certificate of Need (CON) to initiate radiation therapy at its hospital campus located in Germantown, Tennessee

    Bass, Berry & Sims served as co-counsel to Methodist Le Bonheur Healthcare (MLH) in its efforts to obtain a Certificate...
    Client Type: Nonprofit
  • Represented Tivity Health, Inc. in its acquisition of Nutrisystem, Inc.

    We represented Tivity Health, Inc. (Nasdaq: TVTY) in its acquisition of Nutrisystem, Inc. (Nasdaq: NTRI), a provider of weight management...
    Client Type: Public Company
  • Served as main counsel on the recent Columbus Crew acquisition by a private investor group led by Dee and Jimmy Haslam (Crew SC Holdings)

    We served as main counsel on the recent Columbus Crew acquisition by a private investor group led by Dee and...
    Client Type: Private Company